000			01684nam a22002057a 4500
001			20220304113954.0
003			OSt
005			20240305192402.0
008			220304b |||||||| |||| 00| 0 eng d
020			_a9789535172765
020			_a 953517276X
040			_cData centre
100			_aSamir A. Farghaly _927980
245			_aGynecologic Cancers _b Basic Sciences, Clinical and Therapeutic Perspectives
260			_aLondon _b IntechOpen _c 2016
300			_a340 pages
520			_aGynecologic cancers include malignancies of the female genital tract involving the vulva, vagina, cervix, uterus, fallopian tubes or ovaries. In the USA, 98,280 women had gynecological cancers in 2015, and 30,440 died of these cancers. World wide, the number of women who had cancers of the female genital tract was 1,085,900, in 2012 and the number of deaths was 417,600. Cancers of the uterus, cervix and ovary are most common. Widespread screening with the Pap test has allowed physicians to find per-cancerous changes in the cervix and vagina. This has assisted in identifying some invasive cancers early. Multidisciplinary team of experts includes specialists in medical oncology, gynecologic oncology, radiology, urology, radiotherapy, and surgery who work together to determine the best treatment approach for the patient. Recent progress in the development of new surgical techniques has transformed the treatment of gynecologic cancers, resulting in greater surgical precision and fewer complications. In addition targeted adjuvant therapy has become useful in improving the oncologic outcome of patients with these cancers.
600			_xOncology _929434
942			_2ddc _cEB
999			_c5844 _d5844